My Lung Cancer is stable but not shrinking — is treatment still working

Understanding Stable Lung Cancer During Treatment

This is an excellent and common question. The short answer: yes, stable disease can absolutely mean your treatment is working, even if the tumor isn't shrinking. Let me explain how doctors think about this.

How Oncologists Evaluate Treatment Response

When assessing whether lung cancer treatment is effective, your medical team looks at several outcomes, not just tumor shrinkage:

Response Categories (from NCCN Lung Cancer Guidelines):

• Complete Response (CR): Cancer disappears completely
• Partial Response (PR): Tumor shrinks by 30% or more
• Stable Disease (SD): Tumor stays roughly the same size (less than 30% growth or shrinkage)
• Progressive Disease (PD): Tumor grows by 25% or more

The key insight: Stable disease is considered a positive response to treatment. It means your cancer is not advancing—the treatment is holding it in check.

Why Stable Disease Matters

Think of it this way: without treatment, your cancer would likely be growing. Stable disease means your treatment is:

• Preventing growth
• Buying time
• Potentially allowing you to live longer with better quality of life
• Keeping options open for future treatments

According to NCCN Guidelines for Non-Small Cell Lung Cancer, stable disease is an acceptable treatment outcome, especially when:

• You're tolerating the medication well
• You're maintaining quality of life
• There are no new concerning symptoms
• Your imaging shows no new areas of cancer

Important Context for Your Situation

However, YOUR specific situation requires your doctor's full evaluation. Here are critical questions to ask your oncology team:

1. "Is my stable disease what you expected at this point in treatment?" (Different drugs have different timelines for response)

2. "How long do you typically see stable disease last with my current treatment?" (This helps you understand what to expect)

3. "Are there any concerning changes in my scans—even if the main tumor isn't growing?" (New spots or changes matter, not just size)

4. "What's our plan if the cancer starts growing?" (Understanding next steps reduces anxiety)

5. "Are there any biomarkers or genetic tests that might help us predict how long this treatment will work?" (This is especially relevant for lung cancer, where mutations like EGFR, ALK, or PD-L1 status guide treatment)

Additional Monitoring Tools

Your doctor may also use blood-based tests to monitor your response. For example, FirstLook Lung is an emerging early cancer detection test that analyzes circulating tumor DNA (ctDNA) in your blood using advanced sequencing. According to OpenOnco's documentation, this type of test can detect cancer-related DNA patterns with high sensitivity (80%) and particularly strong performance in detecting Stage II-III disease (88-89% sensitivity). While primarily used for screening, such tests may provide additional information about disease burden over time.

The Bottom Line

Stable disease during treatment is genuinely good news. Your treatment is working by preventing progression. Many patients live well for extended periods on stable disease, and new treatment options continue to emerge.

Your oncologist will determine the most appropriate next steps based on:

• How long your disease remains stable
• Your overall health and side effects
• New treatment options that may become available
• Your personal goals and preferences

---

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.